Drugs

Do GLP-1RAs alter the risk of developing age-related macular degeneration (AMD)?

Study compares the risk of developing nonexudative AMD and its progression to exudative AMD in patients with obesity taking GLP-1RAs vs other weight-loss drugs.
October drug roundup: three new Health Canada advisories

Get the info you need on these new Health Canada advisories, part of our drug news roundup for October.
October drug roundup: 13 new indications

Get the info you need on these new indications, part of our drug news roundup for October.
Pharmacist guilty of negligence after a patient misused a medication

The Disciplinary Board criticized the pharmacist for not directly explaining how to safely use the product. In response to pharmacists' outcry over this and other recent harsh penalties, the Board trustee resigned.
Myo-inositol doesn’t lower risk of pregnancy complications in PCOS patients: study

When compared to a placebo, myo-inositol supplements did not reduce incidences of pregnancy complications in people with PCOS.
Drug News—October 2025

A review of new launches, new indications, new dosage forms and Health Canada advisories.
New topical JAK inhibitor available for treating chronic hand eczema

Anzupgo (delgocitinib topical cream) is indicated for the treatment of moderate to severe chronic hand eczema in adults.
NEW PRODUCT: Hepcludex for hepatitis D

Get the info you need on this new product, part of our drug news roundup for October.

Some systemic drugs may be under-recognized causes of maculopathy